Refine Your Search

  • Solutions

  • Therapeutic Areas

  • Resource Type

Accelerating Therapeutics for COVID-19

This webinar will explain lessons learned from preparing for and responding to viral outbreaks such as H5N1 and pH1N1 influenza and discuss how insights from model-informed drug development approaches can spur access to medicines for patients.

Speaker(s): Dr. Dan Hartman - Director of Integrated Development - Bill & Melinda Gates Foundation,
Dr. Steven Kern - Deputy Director of Quantitative Sciences - Bill & Melinda Gates Foundation,
Dr. Craig Rayner - President of Integrated Drug Development - Certara
Dr. Fran Brown - SVP of Integrated Drug Development - Certara
Solution: Clinical Pharmacology Strategy, Evidence and Access, PBPK Modeling & Simulation, PK/PD Modeling & Simulation
Therapeutic Area: Infectious Disease
More Info



Powered by Translations.com GlobalLink OneLink Software